Latest debt-to-equity ratio
Celldex Therapeutics Debt-to-equity ratio
Direct answer
Celldex Therapeutics's debt-to-equity ratio is 0.69%.
The verified market snapshot reports 0.69%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 22, 2026.
Get free Celldex Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 0.69%
Explore related company data
View Celldex Therapeutics's market capitalizationView Celldex Therapeutics's price-to-book ratioView Celldex Therapeutics's return on equityView Celldex Therapeutics's 52-week price rangeView Celldex Therapeutics's revenue growthView Celldex Therapeutics's profit marginView all Celldex Therapeutics key metricsReturn to Celldex Therapeutics profile